Aug. 6, 2020—Deborah Lannigan and colleagues identify a key regulator of the estrogen receptor and suggest that its downregulation by oral contraceptives may increase oxidative stress and DNA damage, a common cause of cancer.
Jun. 11, 2020—Vanderbilt researchers have developed what appears to be a simple and promising treatment for breast cancer metastasis.
Mar. 12, 2020—Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.
Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.
Feb. 19, 2020—The two-year, $125,000 award will allow Marjan Rafat and her research group to investigate how radiation influences tumor and immune cell recruitment in triple negative breast cancer.
Feb. 10, 2020—A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy.
Jan. 23, 2020—Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.
Oct. 22, 2019—Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.
Oct. 17, 2019—A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
Oct. 8, 2019—Health Plus will promote breast cancer awareness at the VU Benefits Open House on Wednesday, Oct. 23.
Sep. 19, 2019—The Think Pink! Breast Cancer Awareness Expo is scheduled from 11 a.m. to 1 p.m. Wednesday, Oct. 2, in the Light Hall North Lobby. Visit the expo to learn about breast cancer prevention, screenings and more.
Aug. 27, 2019—Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.